Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
European Journal of Neurology|April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteersJ J Ferreira, K Desboeuf, M Galitzky, et al.
Stereotactic and Functional Neurosurgery|January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contactsP Cintas, M Simonetta-Moreau, F Ory, et al.
Annals of Neurology|June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's diseaseO Rascol, O Blin, C Thalamas, et al.
Parasitology Research|October 1, 2011
In vitro anthelmintic activity of the essential oils of Zanthoxylum zanthoxyloides and Newbouldia laevis against Strongyloides rattiP A Olounladé, E V B Azando, M S Hounzangbé-Adoté, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 21, 2009
Neuronal in vitro models for the estimation of acute systemic toxicityA Forsby, A K Bal-Price, A Camins, et al.
Pageof 7